Similar articles

• Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia.

  Brito FS Jr, Rosa WC, Arruda JA, Tedesco H, Pestana JO, Lima VC. Brito FS Jr, et al. Catheter Cardiovasc Interv. 2005 Apr;64(4):413-8. doi: 10.1002/ccd.20332. Catheter Cardiovasc Interv. 2005. PMID: 15789385 Clinical Trial.
• [Prevention of restenosis after coronary stenting, problem soon resolved].

  Kivelä A, Hartikainen J. Kivelä A, et al. Duodecim. 2005;121(11):1227-36. Duodecim. 2005. PMID: 15999982 Review. Finnish. No abstract available.
• Percutaneous coronary intervention for left main coronary artery disease.

  Gauthier N, Le May MR. Gauthier N, et al. Expert Rev Cardiovasc Ther. 2007 Mar;5(2):213-20. doi: 10.1586/14779072.5.2.213. Expert Rev Cardiovasc Ther. 2007. PMID: 17338666 Review.
• [Problem with restenosis in connection to balloon angioplasty near to be solved].

  Aalto T, Stjernvall J. Aalto T, et al. Duodecim. 2002;118(10):977-8. Duodecim. 2002. PMID: 12238004 Finnish. No abstract available.
• Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis.

  Cha DH, Ajani AE, Cheneau E, Waksman R. Cha DH, et al. J Invasive Cardiol. 2002 Jul;14(7):432-7. J Invasive Cardiol. 2002. PMID: 12082202 Review.